Related Experiment Video
Updated: Jul 7, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Antenatal Corticosteroid Exposure in Late Preterm Infants: Clinical Considerations in Diabetic Mothers
Hannah Daniel1, Esther S Kim2, Tristan Grogan3
1Department of Pediatrics, University of California, Los Angeles Mattel Children's Hospital, Los Angeles, USA.
None:
Objective The objective of this study was to evaluate the association between antenatal corticosteroid (ACS) administration and respiratory and metabolic outcomes among late preterm infants, with a secondary exploratory analysis of infants of diabetic mothers. Methods We performed a retrospective cohort study of 85 neonates born between 33 0/7 and 35 6/7 weeks' gestation at a county hospital to investigate neonatal outcomes according to ACS exposure. Outcomes included respiratory support requirement, duration to room air, hypoglycemia, and hospital length of stay. Results Among 85 infants, 18 (21%) received no ACS, 24 (28%) received one dose, and 43 (51%) received two doses. ACS exposure was not associated with increased hypoglycemia (p = 0.163) or hospital length of stay (p = 0.647). Among infants requiring respiratory support (n = 30), greater ACS exposure was associated with fewer days to room air (Spearman's rho = -0.37, p = 0.044). Conclusions In this small retrospective cohort, ACS exposure was associated with shorter time to room air among late preterm infants requiring respiratory support, without increased risk of hypoglycemia. These findings are exploratory and hypothesis generating, particularly for infants of diabetic mothers.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Complications of Diabetes Mellitus
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology